Vanguard Group »

Inozyme Pharma shares owned by Vanguard Group

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 2.4M 4.26
2023-09-30 $9.6M 2.3M 4.20
2023-06-30 $7.8M 1.4M 5.57
2023-03-31 $7.6M 1.3M 5.73
2022-12-31 $1.4M 1.3M 1.05
2022-06-30 $6.5M 1.4M 4.77
2022-03-31 $2.0M 490k 4.09
2021-09-30 $7.1M 611k 11.59
2021-06-30 $5.7M 335k 16.99
2021-03-31 $6.7M 341k 19.77
2020-12-31 $6.4M 309k 20.63
2020-09-30 $7.8M 297k 26.29